- Pharmaceutical companies
- Pfizer
Pfizer
Phone: +12127332323
| Type | Public |
|---|---|
| Traded as |
|
| Industry |
|
| Founded | 1849 (1849) in New York City |
| Founders |
|
| Headquarters | 235 East 42nd Street, New York City, U.S. |
| Area served | Worldwide |
| Key people | Albert Bourla, (CEO) |
| Products |
|
| Revenue | |
| Operating income | |
| Net income | |
| Total assets | |
| Total equity | |
| Number of employees | 79,000 (2021) |
| Website | www.pfizer.com |
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
For detailed contact information visit location pages below.
Pfizer's locations around the world
Clinical Trials sponsored by Pfizer
-
Pfizerまだ募集していません
-
Pfizerまだ募集していません
-
Pfizerまだ募集していません肥満 | 過栄養 | 栄養障害 | 太りすぎ | 体重 | 過体重または肥満 | 過体重および/または肥満 | 栄養および代謝疾患アメリカ
-
Pfizerまだ募集していませんがん | 肺新生物 | 非小細胞肺がん | 肺疾患 | 非小細胞肺 | 非小細胞肺癌 (NSCLC) | 非小細胞肺がん、扁平上皮がん | 非小細胞肺がん、非扁平上皮がん | 肺がん(NSCLC)
-
Pfizer募集
-
Pfizer募集肥満と過体重アメリカ, スペイン, ブルガリア, ポーランド, ドイツ, イギリス, チェコ, アルゼンチン, ルーマニア, カナダ, スロバキア